1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of CLGN mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO RGD:1343269 6480464 Estradiol results in increased expression of CLGN mRNA CTD PMID:19619570 17beta-estradiol multiple interactions ISO RGD:1592643 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of CLGN mRNA CTD PMID:26496021 17beta-estradiol multiple interactions ISO RGD:1343269 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CLGN mRNA CTD PMID:19619570 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1343269 6480464 Dihydrotestosterone results in increased expression of CLGN mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1343269 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CLGN mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1343269 6480464 Tetrachlorodibenzodioxin results in decreased expression of CLGN mRNA CTD PMID:19619570 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:1592643 6480464 2 more ... CTD PMID:32109520 2,3-dimethoxynaphthalene-1,4-dione decreases expression ISO RGD:1343269 6480464 2 more ... CTD PMID:17547211 3,4-dichloroaniline increases expression ISO RGD:1343269 6480464 3, 4-dichloroaniline results in increased expression of CLGN mRNA CTD PMID:24172598 3,7-dihydropurine-6-thione decreases expression ISO RGD:1592643 6480464 Mercaptopurine results in decreased expression of CLGN mRNA CTD PMID:23358152 6-propyl-2-thiouracil decreases expression ISO RGD:1592643 6480464 Propylthiouracil results in decreased expression of CLGN mRNA CTD PMID:24780913 , PMID:25825206 6alpha-methylprednisolone decreases expression ISO RGD:1343269 6480464 Methylprednisolone results in decreased expression of CLGN mRNA CTD PMID:19192274 8-Br-cAMP increases expression ISO RGD:1343269 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CLGN mRNA CTD PMID:20147733 , PMID:22079614 aflatoxin B1 decreases methylation ISO RGD:1343269 6480464 Aflatoxin B1 results in decreased methylation of CLGN gene CTD PMID:27153756 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of CLGN mRNA CTD PMID:16604517 all-trans-retinoic acid decreases expression ISO RGD:1343269 6480464 Tretinoin results in decreased expression of CLGN mRNA CTD PMID:21934132 ampicillin decreases expression ISO RGD:1343269 6480464 Ampicillin results in decreased expression of CLGN mRNA CTD PMID:21632981 antimony(0) decreases expression ISO RGD:1343269 6480464 Antimony results in decreased expression of CLGN mRNA CTD PMID:17547211 arsenous acid decreases expression ISO RGD:1343269 6480464 Arsenic Trioxide results in decreased expression of CLGN mRNA CTD PMID:17547211 azathioprine decreases expression ISO RGD:1343269 6480464 Azathioprine results in decreased expression of CLGN mRNA CTD PMID:19192274 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1343269 6480464 7 more ... CTD PMID:20382639 bicalutamide increases expression ISO RGD:1343269 6480464 bicalutamide results in increased expression of CLGN mRNA CTD PMID:15638997 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1343269 6480464 Diethylhexyl Phthalate results in decreased expression of CLGN mRNA CTD PMID:31163220 bisphenol A multiple interactions ISO RGD:1592643 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of CLGN mRNA CTD PMID:26496021 bisphenol A affects expression ISO RGD:1343269 6480464 bisphenol A affects the expression of CLGN mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:1343269 6480464 bisphenol A analog results in increased expression of CLGN mRNA, bisphenol A results in increased expression of CLGN mRNA CTD PMID:27685785 , PMID:32387340 bisphenol A decreases expression ISO RGD:1592643 6480464 bisphenol A results in decreased expression of CLGN mRNA CTD PMID:25181051 , PMID:30816183 butanal increases expression ISO RGD:1343269 6480464 butyraldehyde results in increased expression of CLGN mRNA CTD PMID:26079696 cadmium atom decreases expression ISO RGD:1343269 6480464 Cadmium results in decreased expression of CLGN mRNA CTD PMID:17547211 cadmium dichloride decreases expression ISO RGD:1343269 6480464 Cadmium Chloride results in decreased expression of CLGN mRNA CTD PMID:17547211 calcitriol increases expression ISO RGD:1343269 6480464 Calcitriol results in increased expression of CLGN mRNA CTD PMID:16002434 chromium atom decreases expression ISO RGD:1343269 6480464 Chromium results in decreased expression of CLGN mRNA CTD PMID:17547211 cisplatin increases expression ISO RGD:1343269 6480464 Cisplatin results in increased expression of CLGN mRNA CTD PMID:27594783 clorgyline increases expression ISO RGD:1343269 6480464 Clorgyline results in increased expression of CLGN mRNA CTD PMID:19691856 copper atom multiple interactions ISO RGD:1343269 6480464 [NSC 689534 binds to Copper] which results in increased expression of CLGN mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1343269 6480464 [NSC 689534 binds to Copper] which results in increased expression of CLGN mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:1343269 6480464 Copper Sulfate results in decreased expression of CLGN mRNA CTD PMID:19549813 cyclosporin A increases expression ISO RGD:1343269 6480464 Cyclosporine results in increased expression of CLGN mRNA CTD PMID:20106945 more ... dexamethasone decreases expression ISO RGD:1343269 6480464 Dexamethasone results in decreased expression of CLGN mRNA CTD PMID:25047013 diarsenic trioxide decreases expression ISO RGD:1343269 6480464 Arsenic Trioxide results in decreased expression of CLGN mRNA CTD PMID:17547211 dicrotophos decreases expression ISO RGD:1343269 6480464 dicrotophos results in decreased expression of CLGN mRNA CTD PMID:28302478 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate decreases expression ISO RGD:1343269 6480464 Antimony Potassium Tartrate results in decreased expression of CLGN mRNA CTD PMID:17547211 disodium selenite increases expression ISO RGD:1343269 6480464 Sodium Selenite results in increased expression of CLGN mRNA CTD PMID:24383545 diuron increases expression ISO RGD:1343269 6480464 Diuron metabolite results in increased expression of CLGN mRNA CTD PMID:24172598 dorsomorphin multiple interactions ISO RGD:1343269 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 doxorubicin affects expression ISO RGD:1343269 6480464 Doxorubicin affects the expression of CLGN mRNA CTD PMID:29803840 entinostat increases expression ISO RGD:1343269 6480464 entinostat results in increased expression of CLGN mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:1343269 6480464 Ethanol results in increased expression of CLGN mRNA CTD PMID:28986285 ethyl methanesulfonate increases expression ISO RGD:1343269 6480464 Ethyl Methanesulfonate results in increased expression of CLGN mRNA CTD PMID:23649840 folic acid increases expression ISO RGD:1343269 6480464 Folic Acid results in increased expression of CLGN mRNA CTD PMID:11723236 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of CLGN mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:1343269 6480464 Formaldehyde results in increased expression of CLGN mRNA CTD PMID:23649840 irinotecan increases expression ISO RGD:1343269 6480464 Irinotecan analog results in increased expression of CLGN mRNA CTD PMID:18927307 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of CLGN mRNA CTD PMID:22609695 leflunomide increases expression ISO RGD:1343269 6480464 leflunomide results in increased expression of CLGN mRNA CTD PMID:28988120 lucanthone decreases expression ISO RGD:1343269 6480464 Lucanthone results in decreased expression of CLGN mRNA CTD PMID:21148553 mercaptopurine decreases expression ISO RGD:1592643 6480464 Mercaptopurine results in decreased expression of CLGN mRNA CTD PMID:23358152 mercury atom decreases expression ISO RGD:1343269 6480464 Mercury results in decreased expression of CLGN mRNA CTD PMID:17547211 mercury(0) decreases expression ISO RGD:1343269 6480464 Mercury results in decreased expression of CLGN mRNA CTD PMID:17547211 methotrexate decreases expression ISO RGD:1343269 6480464 Methotrexate results in decreased expression of CLGN mRNA CTD PMID:19192274 methyl methanesulfonate increases expression ISO RGD:1343269 6480464 Methyl Methanesulfonate results in increased expression of CLGN mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1343269 6480464 methylmercuric chloride results in decreased expression of CLGN mRNA CTD PMID:28001369 mitomycin C affects response to substance ISO RGD:1343269 6480464 CLGN protein affects the susceptibility to Mitomycin CTD PMID:16217747 N-methyl-4-phenylpyridinium increases expression ISO RGD:1343269 6480464 1-Methyl-4-phenylpyridinium results in increased expression of CLGN mRNA CTD PMID:24810058 panobinostat decreases expression ISO RGD:1343269 6480464 panobinostat results in decreased expression of CLGN mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1343269 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of CLGN mRNA CTD PMID:27188386 paracetamol increases expression ISO RGD:1343269 6480464 Acetaminophen results in increased expression of CLGN mRNA CTD PMID:29067470 perfluorononanoic acid increases expression ISO RGD:1343269 6480464 perfluorononanoic acid results in increased expression of CLGN mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1343269 6480464 perfluorooctane sulfonic acid results in increased expression of CLGN mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1343269 6480464 perfluorooctane sulfonic acid results in decreased expression of CLGN mRNA CTD PMID:27153767 perfluorooctanoic acid increases expression ISO RGD:1343269 6480464 perfluorooctanoic acid results in increased expression of CLGN mRNA CTD PMID:32588087 phenylmercury acetate decreases expression ISO RGD:1343269 6480464 Phenylmercuric Acetate results in decreased expression of CLGN mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1343269 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of CLGN mRNA CTD PMID:27188386 piroxicam decreases expression ISO RGD:1343269 6480464 Piroxicam results in decreased expression of CLGN mRNA CTD PMID:19192274 potassium chromate increases expression ISO RGD:1343269 6480464 potassium chromateVI results in increased expression of CLGN mRNA CTD PMID:22714537 potassium dichromate decreases expression ISO RGD:1343269 6480464 Potassium Dichromate results in decreased expression of CLGN mRNA CTD PMID:17547211 prednisolone decreases expression ISO RGD:1343269 6480464 Prednisolone results in decreased expression of CLGN mRNA CTD PMID:19192274 progesterone decreases expression ISO RGD:1343269 6480464 Progesterone results in decreased expression of CLGN mRNA CTD PMID:21540246 purine-6-thiol decreases expression ISO RGD:1592643 6480464 Mercaptopurine results in decreased expression of CLGN mRNA CTD PMID:23358152 quercetin decreases expression ISO RGD:1343269 6480464 Quercetin results in decreased expression of CLGN mRNA CTD PMID:21632981 quinolin-8-ol decreases expression ISO RGD:1343269 6480464 Oxyquinoline results in decreased expression of CLGN mRNA CTD PMID:21632981 resveratrol affects expression ISO RGD:1592643 6480464 resveratrol affects the expression of CLGN mRNA CTD PMID:15748624 SB 431542 multiple interactions ISO RGD:1343269 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1343269 6480464 Silicon Dioxide results in decreased expression of CLGN mRNA CTD PMID:25351596 sodium aurothiomalate decreases expression ISO RGD:1343269 6480464 Gold Sodium Thiomalate results in decreased expression of CLGN mRNA CTD PMID:19192274 sulforaphane increases expression ISO RGD:1343269 6480464 sulforafan results in increased expression of CLGN mRNA CTD PMID:31838189 trichostatin A increases expression ISO RGD:1343269 6480464 trichostatin A results in increased expression of CLGN mRNA CTD PMID:24935251 trichostatin A multiple interactions ISO RGD:1343269 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of CLGN mRNA CTD PMID:27188386 trichostatin A decreases expression ISO RGD:1343269 6480464 trichostatin A results in decreased expression of CLGN mRNA CTD PMID:24935251 , PMID:26272509 trimellitic anhydride decreases expression EXP 6480464 trimellitic anhydride results in decreased expression of CLGN mRNA CTD PMID:19042947 valproic acid affects expression ISO RGD:1343269 6480464 Valproic Acid affects the expression of CLGN mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1343269 6480464 Valproic Acid results in increased expression of CLGN mRNA CTD PMID:24935251 more ... vinclozolin increases methylation ISO RGD:1592643 6480464 vinclozolin results in increased methylation of CLGN gene CTD PMID:31079544 vorinostat multiple interactions ISO RGD:1343269 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of CLGN mRNA CTD PMID:27188386 vorinostat decreases expression ISO RGD:1343269 6480464 vorinostat results in decreased expression of CLGN mRNA CTD PMID:26272509 vorinostat increases expression ISO RGD:1343269 6480464 vorinostat results in increased expression of CLGN mRNA CTD PMID:27188386